Obstetrics & Gynecology Doctors in Lewiston, ID Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Sean T Urquhart, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Dr. E. Wayne Day, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 222 Southway Ave Ste A, Lewiston, ID 83501 Phone: 208-746-6111

Dr. Geneen E Bigsby, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Dr. Alex Benton Watson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

Lindsay R Kern, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2315 8th St, Lewiston, ID 83501 Phone: 208-746-1383    Fax: 208-746-6348

News Archive

Doctors not responsible for patient gaps

Australian Medical Association (AMA) President, Dr Mukesh Haikerwal, said it was mischievous of the Australian Health Industry Association (AHIA) to be running around in the media this morning blaming doctors for private patients being confronted with high gap payments.

Knowing allergy triggers allows sufferers to practice avoidance measures

If you spend August sneezing, ragweed may be your allergy enemy. If, like clockwork, you suffer in the spring, tree pollen may be to blame. And if your eyes itch and head feels stuffed up after the first frost should have killed every outdoor allergen, you may have indoor allergies.

New therapeutic approach that could help eliminate dormant HIV infection

US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week's issue of The Lancet.

CytRx reaches agreement with FDA for aldoxorubicin Phase 3 trial for treatment of soft tissue sarcomas

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, announced today that it has reached an agreement with the U.S. Food and Drug Administration under a special protocol assessment for a global pivotal Phase 3 trial with aldoxorubicin as a treatment for patients with soft tissue sarcomas who have relapsed or were refractory following prior treatment with chemotherapy.

Finance Committee continues work on health overhaul, benefits tax advances in negotiations

The Senate Health, Education, Labor and Pensions Committee continued its mark up of health care reform legislation while the Senate Finance Committee "was hunkered down in negotiations on its version, with Finance Committee Chairman Max Baucus (D-Mont.) shuttling between closed-door meetings to try to reach a consensus," Roll Call reports.

Read more Medical News

› Verified 3 days ago